HLPVSPACB• 7 Days (Normalized)
HLP vs PACB (Hongli Group Inc. vs Pacific Biosciences of California Inc.)
Showing Closing Date Range from Sep 29 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
HLP Performance $2.47
-3.14%
Hongli Group Inc.
Normalized Baseline0.00%
PACB Performance $2.87
+56.83%
Pacific Biosciences of California Inc.
Normalized Baseline0.00%
Alpha Spread Margin PACB LEADS
-59.97 pts
PACB outperforming by 59.97 percentage points
HLPPACB
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
HLP PACB
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(5 dates)
| Date | HLP Price | HLP Gain (%) | PACB Price | PACB Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $2.47 | -3.14% | $2.87 | +56.83% | -59.97% |
| Oct 02, 2026 | $2.55 | +0.00% | $2.54 | +38.80% | -38.80% |
| Oct 01, 2026 | $- | $2.51 | +37.16% | - | |
| Sep 30, 2026 | $- | $2.37 | +29.51% | - | |
| Sep 29, 2026 | $- | $1.83 | +0.00% | - |